Hidden Ingredient Discovered in Sexual Enhancement Supplement

The FDA has warned consumers that the sexual enhancement supplement S.W.A.G. contains an undisclosed ingredient and should not be purchased or used.

Nova Dietary Supplements Recalled

Nova Products announced a voluntary recall of African Black Ant, Black Ant, XZen Gold, ZXen Platinum, XZen 1200, XZone Gold, and XZone 1200, products marketed as dietary supplements for sexual enhancement.

Can Stem Cells Help Treat Bladder Issues?

Researchers have coaxed human stem cells into becoming bladder cells that could aid in repairing defective or diseased bladders.

PSA Screening Decreased Since USPSTF Recommendations

Prostate-specific antigen screening has decreased since publication of the U.S. Preventive Services Task Force Recommendations against screening

Resolved Childhood Glomerular Disease Linked to HTN Risk

Resolved childhood glomerular disease is associated with increased subsequent risk of hypertension.

For Prostate Cancer, SBRT Less Costly, More Toxic Than IMRT

For patients with prostate cancer, stereotactic body radiation therapy is less expensive than intensity-modulated radiation therapy, but is associated with more genitourinary toxicity.

Transvaginal Approaches for Vaginal Prolapse

For women undergoing surgery for vaginal prolapse and stress urinary incontinence, outcomes for two common transvaginal approaches are comparable, and perioperative behavioral therapy with pelvic floor muscle training does not improve surgical outcomes

Have Pediatric Kidney Transplant Outcomes Improved?

Over the last 25 years, pediatric kidney transplantation outcomes have improved in the United States.

Hidden Ingredient Found in Sexual Enhancement Supplement

The FDA has warned consumers that the sexual enhancement supplement Weekend Warrior contains an undisclosed ingredient and should not be purchased or used.

Baxter Recalls Peritoneal Dialysis Solution

Baxter announced a voluntary recall of a single lot of DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose 6000mL (Ambu-Flex II).

Pregnancy Timing Affected by Male Phthalate Levels

High concentrations of three common forms of phthalates in men have been shown to impact fertility in couples trying to conceive.

Study Comparing IV Iron Drugs Shows Similar Efficacy in Patients with CKD

Ferumoxytol and iron sucrose have comparable safety in the treatment of anemia in patients with CKD.

Warfarin Linked to Lower Cardiac Risk in CKD With A-Fib

For patients with established cardiovascular disease and atrial fibrillation, warfarin treatment correlates with a lower risk of a composite of death, myocardial infarction (MI), and ischemic stroke, with no increased risk of bleeding.

DASH Diet May Lower Risk of Recurrent Kidney Stones

The DASH diet may be an effective alternative to the low-oxalate diet for reducing risk of kidney stone recurrence.

Thermal Receipt Handling Impacts Urinary BPA Concentration

Thermal receipt handling is associated with increased urinary concentrations of bisphenol A (BPA).

Repeat Biopsies Up Infection Risk in Prostate Cancer Patients

For men with prostate cancer who are under active surveillance, repeated biopsies are associated with increased risk of infectious complications.

FDA Accepts sBLA for Xiaflex for Concurrent Treatment of Multiple Palpable Cords

The FDA has accepted Auxilium's supplemental Biologics License Application (sBLA) for Xiaflex (collagenase clostridium histolyticum, or CCH) for the treatment of two Dupuytren's contracture (DC) cords concurrently.

Intensive Dialysis Improves Pregnancy Outcomes

For women with end-stage renal disease (ESRD), intensive hemodialysis is associated with improved pregnancy outcomes.

Tamoxifen Found in Samples of Dietary Supplement

Tamoxifen that has been identified in samples of the dietary supplement Esto Suppress.

Bayer HealthCare Initiates Colorectal Cancer Trial with Stivarga

Bayer HealthCare announced that it has begun enrolling patients into the Phase 3 COAST trial studying Stivarga (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.

Androgen Deprivation Therapy Can Take Emotional Toll

Changes in mental and emotional well-being occur in prostate cancer patients on androgen deprivation therapy (ADT).

Positive Results for Prostate Cancer Treatment with Xtandi

Medivation and Astellas Pharma announced results from their Phase 3 PREVAIL trial of Xtandi (enzalutamide) in patients with chemotherapy-naive metastatic prostate cancer who have failed androgen deprivation therapy and have few or no symptoms.

Sexual Enhancement Supplements Tainted, Says FDA

The FDA is warning consumers that several sexual enhancement supplements have been found to contain hidden ingredients, and that these products should not be purchased or used.

Kidney Injury Not Uncommon After Cardiovascular Intervention

Acute kidney injury (AKI) is seen in about 7% of patients undergoing percutaneous coronary intervention (PCI) and is associated with significant in-hospital mortality.

Positive Results with ZS-9 for Hyperkalemia

ZS Pharma announced top-line results from its Extended Treatment Phase of ZS003, a Phase 3 trial of ZS-9 for the treatment of hyperkalemia.

Auxilium Submits Xiaflex sBLA for Concurrent Treatment Of Multiple Palpable Cords

Auxilium announced that it has submitted a supplemental Biologics License Application (sBLA) to the FDA for Xiaflex (collagenase clostridium histolyticum) for the treatment of multiple Dupuytren's contracture (DC) cords concurrently.

Neuraxial + General Anesthesia May Up Prostate CA Outcomes

Researchers found that GA alone correlated with significantly increased risk for systemic progression and elevated overall mortality within 90 postoperative days.

Long-Lasting Erections Linked to Certain ADHD Medications

The FDA is warning the public that methylphenidate products may cause priapism.

Integrated Care Endorsed for Castration-Resistant Prostate CA

For patients with castration-resistant prostate cancer (CRPC), a therapeutic framework should involve an integrated approach, with joint management by a urologist and medical oncologist

Baseline Inflammation Linked to Lower PCa Risk on Repeat Biopsy

Both acute and chronic inflammation correlated significantly with a lower risk of PCa at the two-year biopsy,

Wider Statin Use Recommended for Chronic Kidney Disease

New guidelines for lipid management in chronic kidney disease (CKD) recommend wider statin use.

First Drug Therapy for Peyronie's Disease Approved

The FDA has approved a new indication for Xiaflex (collagenase clostridium histolyticum; Auxilium) for the treatment of Peyronie's disease, a curvature deformity of the penis due to the presence of a plaque.

Optimal Testosterone Levels Tied to Survival in Older Men

Higher and lower levels of testosterone (T) and its metabolites may raise mortality risk in older men.

Testosterone Therapy Doesn't Worsen Urinary Symptoms

Testosterone replacement therapy is associated with a low risk of worsening lower urinary tract symptoms for hypogonadal men.

Stunted Growth More Likely in CKD Children from Lower-Income Families

Results from the CKiD Study found that children and adolescents with chronic kidney disease were less likely to grow to normal height ranges if they came from lower-income families, even with more prescriptions for growth hormone.

Alpha Male Pill Contains Six Hidden Ingredients

The FDA is warning consumers to not buy or use Alpha Male, a product sold for sexual enhancement.

Recall: P-Boost and NatuRECT Found to Contain Tadalafil

Tendex is recalling one lot of P-Boost (Lot # F51Q) and one lot of NatuRECT (Lot # F51Q) after the FDA determined the products contained undeclared tadalafil. These products are sold as dietary supplements for sexual enhancement.

Renal Denervation Viable for Achieving BP Control

For patients with treatment-resistant hypertension and chronic kidney disease, renal denervation (RDN) reduces blood pressure (BP) and can slow renal function decline.

Two Companies Recall Sexual Enhancement Supplements

The FDA notified the public that Fossil Fuel Products and Jobbers Wholesale are voluntarily recalling some sexual enhancement supplements after they were found to contain several undeclared drug ingredients.

Do Renal Artery Stents Lead to Better Outcome vs. Medication-Only?

According to results from a National Institutes of Health-funded study, a commonly used stenting procedure in the renal artery appears to offer no significant improvement when added to medication-based therapy.

Retinal Damage Linked to Atrial Fibrillation

Micro-vessel disease in retina and kidneys are independently and interactively associated with higher risk of atrial fibrillation.

Counterfeit Supplement Found to Contain Sildenafil

The FDA is warning the public about a potentially harmful counterfeit male sexual enhancement supplement called ExtenZe Maximum Strength.

Enterococci, GBS Appear to Rarely Cause Acute Cystitis

But low levels of E. coli had a high positive predictive value for bladder bacteriuria.

High-Risk Gene May Predict Kidney Failure in African-Americans

According to a recent study, a gene variant commonly found in African-Americans predicts that people with that gene who also have chronic kidney disease (CKD) are twice as likely to progress to kidney failure as African-Americans without the high-risk gene and white people with CKD.

Results Announced for ZS-9 for Hyperkalemia

ZS Pharma has announced top-line results from the acute phase of its pivotal Phase 3 ZS-003 trial of ZS-9, an investigational treatment for hyperkalemia.

ASN: Calcium-Channel Blocker-Antibiotic Combo Impacts Kidneys

For older adults, co-prescription with clarithromycin vs. azithromycin and calcium-channel blockers is associated with increased risk of hospitalization with acute kidney injury.

ASN: Bardoxolone Methyl No Benefit in T2DM, Stage 4 CKD

Bardoxolone methyl does not reduce the risk of end-stage renal disease (ESRD) or cardiovascular death in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.

ASN: Particulate Matter at Ground Zero, Albuminuria Linked

For first responders exposed to particulate matter at Ground Zero, high exposure is associated with albuminuria.

Vitalikor Sex Supplement Found to Contain Hidden Ingredients

The FDA is advising consumers to not purchase or use Vitalikor Fast Acting, a sexual enhancement supplement sold on various websites and retail stores.

Study Raises Questions About Testosterone Rx for 'Low T'

Testosterone therapy use was associated with an increased risk of adverse outcomes.

Acute Kidney Injury Increased for Some Over Last Decade

Over the last decade there has been an increase in the incidence of acute kidney injury (AKI), but a decrease in the incidence of AKI requiring dialysis, among elderly patients hospitalized with a heart attack who have undergone percutaneous coronary intervention.

Renacidin Irrigation Shipments to Resume

United-Guardian announced that Renacidin Irrigation (citric acid, glucono delta-lactone, magnesium carbonate) is available again after a series of manufacturing issues.

FDA Approves Addition to Cialis Labeling

Eli Lilly announced that the FDA has approved an addition to the Cialis (tadalafil) label to include data from a 26-week study that showed Cialis 5mg once daily started in combination with finasteride significantly improved the signs and symptoms of benign prostatic hyperplasia (BPH) as early as 4 weeks.

Increased Use of IMRT for Self-Referring Urologists

Use of integrated intensity-modulated radiation therapy (IMRT) has increased more among urologists in private practice.

Physical Symptoms From Prostate Biopsy Can Cause Anxiety

Problematic symptoms of prostate biopsy can lead to increased anxiety in men, even when the biopsy results are negative for cancer.

ACP Recommendations on CKD Management

The American College of Physicians (ACP) has presented recommendations for the screening, monitoring, and treatment of adults with chronic kidney disease.

Post-Op EPIC Scores Predict Functional Outcomes

Three-month scores on the Expanded Prostate Cancer Index Composite (EPIC) predict urinary and sexual functional outcomes at 12 months.

Psoriasis Linked to Increased Risk of Chronic Kidney Disease

Moderate or severe psoriasis is associated with chronic kidney disease.

Rates of PSA Screening in Older Men Vary Among Doctors

About 27% of the variance in whether a man received PSA screening was explained by which PCP was providing his care.

ASRM: Vasectomy Timing Associated With Financial Crisis

Men considering a vasectomy after the financial crisis in 2008 had significantly fewer children compared with men considering the procedure before the crisis.

ASRM: Studies Examine Impact of Lifestyle on Sperm Quality

Lifestyle behaviors such as caffeine and alcohol intake and physical activity may impact sperm quality parameters.

ASRM: Male Phthalate Levels Linked to Lower Fecundability

Male concentrations of phthalates correlate with diminished couple fecundability, while increased maternal conjugated bisphenol A (BPA) levels correlate with miscarriage.

Does Antibacterial Honey Prevent Peritoneal Dialysis Infections?

Daily application of antibacterial honey at the exit site is not associated with increased time to peritoneal-dialysis-related infections.

Prostate Cancer Screening Cost $447 Million in 2009

Men in regions with the highest screening costs were significantly more likely to be diagnosed with prostate cancer and localized cancer.

Antibodies Predict Graft Injury, Loss in Kidney Transplants

The addition of the presence of complement-binding donor-specific anti-HLA antibodies to a traditional risk model improved the prediction of graft failure.

Chronic Kidney Disease Up in the Oldest Old in the U.S.

The prevalence of chronic kidney disease (CKD) has increased among U.S. adults aged ≥80 years.

Over-the-Counter OAB Patch Available for Women

Merck Consumer announced that Oxytrol for Women (oxybutynin transdermal system) is now available over-the-counter (OTC) to treat women with an overactive bladder.

FDA: More Tainted Sexual Enhancement Supplements

The FDA is advising consumers not to purchase or use Xzen Xpress, Wood-E, or X-Zone Premium supplements because they were found to contain hidden drug ingredients.

Implications of Very Low Risk Prostate Cancer Assessed

The risk of adverse findings at surgery for men with very low risk (VLR) prostate cancer is significantly lower than for those with low risk (LR).

PSA Testing Tied to Higher Socioeconomic Status

Prostate-specific antigen testing is more likely among affluent men.

Surgery Better Than Physical Therapy for Incontinence

Midurethral-sling surgery is more effective than physical therapy for women with stress urinary incontinence.

Detection Bias May Explain Raised Bladder CA Risk in T2DM

Early detection bias may explain the pattern of increased bladder cancer risk previously reported in patients with type 2 diabetes.

FDA Approves UroLift System for Enlarged Prostate

The FDA has authorized the marketing of NeoTract Inc.'s UroLift system, a permanent implant to relieve low or blocked urine flow in men with an enlarged prostate.

Low Testosterone Levels Linked to Estradiol Deficiency

Declines in testosterone levels as well as estradiol deficiences account for the clinical manifestations of testosterone deficiency in men.

Patiromer Demonstrates Efficacy in Hyperkalemia Trial

Relypsa announced positive results for Part A of a two-part pivotal Phase 3 clinical trial evaluating patiromer for the treatment of hyperkalemia.

More Women in Emergency Room for Kidney Stones

There has been an increase in women visiting the emergency room for kidney stones while hospitalization rates have remained stable.

Behavioral Methods Superior to No Tx for Nocturnal Enuresis

Simple behavioral methods are effective for nocturnal enuresis in children but alarm therapy or some drug therapy may be more effective.

Evil Root, Pro Power Max, 72HP Sexual Supplements Recalled

The FDA has requested that Hardmenstore.com voluntarily recall 1000 lots of 72HP, Evil Root, and Pro Power Max following the discovery of a hidden ingredient.

Product Sterility Issues at Wellness Pharmacy

Wellness Pharmacy is voluntarily recalling certain lots of Dexpanthenol, Magnesium Sulfate, Methylcobalamin, Sodium Phenylbutyrate, R.L Glutathione, and Ascorbic Acid due to unreliable sterility results.

Exercise Is Tolerable and Beneficial in Kidney Disease

Exercise training and lifestyle intervention has beneficial effects on cardiorespiratory fitness, body composition, and diastolic function in patients with moderate chronic kidney disease (CKD).

Depression and Nocturia May Be Bidirectionally Linked

There may be a bidirectional association between depression and nocturia.

What's the Ideal BP for Kidney Disease Patients?

In patients with chronic kidney disease (CKD), optimal blood pressure (BP) seems to be 130-159/70-89 mmHg.

Jack Rabbit Supplement Contains Hidden Ingredients

Jack Rabbit is recalling one lot of its sexual enhancement supplement called Jack Rabbit after it was found to contain two undeclared ingredients.

Few Urologists Follow Peri-Op Thromboprophylaxis Guidelines

The use of thromboprophylaxis in patients undergoing urological procedures is low among American Urological Association (AUA) members.

Heavy Smoking Raises Prostate Cancer Risk in Blacks

Researchers find no association in whites.

Percutaneous Tibial Nerve Stimulation Has Lasting Benefit

Percutaneous tibial nerve stimulation with the Urgent PC Neuromodulation System offers sustained overactive bladder symptom improvement after three years of therapy.

Rabies, Fatal Encephalitis Caused by Donated Kidney

Eighteen months after receiving a kidney transplant, a recipient died from acute progressive encephalitis caused by rabies infection that had been undiagnosed in the donor.

Kidney Stones Tied to Coronary Heart Disease in Women

Among women, a history of kidney stones is associated with an increased risk of coronary heart disease (CHD).

Guidance Issued for Erectile Dysfunction As Marker of CVD

Erectile dysfunction (ED) has predictive value for cardiovascular risk and treatment may have beneficial effects.

Testosterone Therapy Does Not Raise Prostate Cancer Recurrence Risk

After radical prostatectomy, men who received testosterone therapy for hypogonadism had a lower rate of biochemical recurrence than nonhypogonadal men.

Mutation ID'd in Some With Kidney, Urinary Tract Disorders

Independent mutations have been identified in the dual serine-threonine and tyrosine protein kinase gene (DSTYK) in patients with congenital abnormalities of the kidney and urinary tract.

Soy Supplement Doesn't Cut Prostate Cancer Recurrence

For men at high risk of biochemical recurrence after radical prostatectomy, daily consumption of a soy protein supplement is not associated with a reduction in the risk of recurrence.

Most Men Report No Shared Decision Making in PSA Screening

Nearly two-thirds of men report an absence of shared decision making related to prostate-specific antigen (PSA) screening.

Renal Disease Significantly Reduces Life Expectancy in SLE

Compromised kidneys significantly reduce survival and life expectancy in patients with systemic lupus erythematosus (SLE).

Three-Gene mRNA Signature IDs Acute Cellular Rejection

A signature composed of three-gene mRNA in urinary cells can identify kidney biopsy samples showing acute cellular rejection.

Kidney Involvement, High Anti-dsDNA Predict Lupus Flares

Kidney involvement and high anti-double stranded (ds) DNA are independent predictors of moderate-severe lupus flare.

Illegal Pharmacy Websites Shutdown by the FDA

The FDA has taken action against over 9,600 websites for online sale and distribution of unapproved prescription medications to consumers.

Sexual Dysfunction Linked to CVD in Extreme-Duration T1DM

For males who have had type 1 diabetes for ≥50 years, sexual dysfunction is associated with large vessel cardiovascular disease.

Intensive Statin Treatment Doesn't Seem to Up Kidney Risk Post-ACS

For post-acute coronary syndrome patients, the risk of kidney injury is comparable for those treated with an intensive or moderate statin regime.

Nephropathic Cystinosis Treatment Available

Procysbi (cysteamine bitartrate delayed-release capsules; Raptor) has been made available for the management of nephropathic cystinosis.

Sign Up for Free e-newsletters